General Information of Drug Transporter (DT)
DT ID	DTD0003 Transporter Info
Gene Name	ABCB1
Protein Name	P-glycoprotein 1
Gene ID	5243
UniProt ID	P08183
Genetic Polymorphisms of DT (GPD)
Genetic Polymorphism	rs2032582
Site of GPD	chr7:87531302 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>C / A>T
Minor Allele Frequency	A=0.3343/1674 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:          17 Drugs in Total
Digoxin	Drug Info	Congestive Cardiac Insufficiency; Arrhythmias; Heart Failure	Correlated with the increased drug serum concentrations in patients (compare with allele C)		[ 1]
Everolimus	Drug Info	Breast Neoplasm	Correlated with the increased likelihood of lymphopenia in patients (compare with allele C)		[ 2]
Mycophenolate mofetil	Drug Info	Kidney Transplantation	Correlated with the increased transplant rejection risk in patients (compare with genotype CC)		[ 3]
Cyclosporine	Drug Info	Kidney Transplantation	Correlated with the increased transplant rejection risk in patients (compare with genotype CC)		[ 3]
Atorvastatin	Drug Info	Hypercholesterolemia	Irrelevant to the dose decrease or drug switching risk in patients (compare with Allele T)		[ 4]
Simvastatin	Drug Info	Hypercholesterolemia	Irrelevant to the dose decrease or drug switching risk in patients (compare with Allele T)		[ 4]
Tacrolimus	Drug Info	Kidney Transplantation	Irrelevant to the dose-adjusted trough concentrations in patients (compare with allele C); Irrelevant to the drug trough concentrations in patients (compare with Allele C)		[ 5], [ 6]
Tacrolimus	Drug Info	Hemopoietic Stem Cell Transplant	Irrelevant to the drug clearance in patients (compare with Allele C)		[ 7]
Tacrolimus	Drug Info	Liver Transplantation	Irrelevant to the drug metabolism in patients (compare with Allele C)		[ 8]
Clomipramine	Drug Info	Depression	Correlated with the increased suicidal ideation risk in patients (compare with allele C)		[ 9]
Nefazodone	Drug Info	Depression	Correlated with the increased suicidal ideation risk in patients (compare with allele C)		[ 9]
Fluoxetine	Drug Info	Depressive Disorder	Correlated with the increased drug response in patients (compare with allele C)		[ 10]
Venlafaxine	Drug Info	Depression	Correlated with the increased suicidal ideation risk in patients (compare with allele C)		[ 9]
Efavirenz	Drug Info	HIV Infection	Correlated with the decreased likelihood of emerging viral drug resistance in patients (compare with allele C)		[ 11]
Paroxetine	Drug Info	Depression	Correlated with the increased suicidal ideation risk in patients (compare with allele C)		[ 9]
Lithium	N.A.	Depression	Correlated with the increased suicidal ideation risk in patients (compare with allele C)		[ 9]
Antiepileptics	N.A.	Epilepsy	Irrelevant to the likelihood of drug resistance in patients (compare with Allele C)		[ 12]
Allele C	Click to Show/Hide the Full List of Affected Drugs:          10 Drugs in Total
Atorvastatin	Drug Info	Coronary Artery Disease	Correlated with the increased drug-induced liver injury risk in patients (compare with Allele T)		[ 13]
Sirolimus	Drug Info	Kidney Transplantation	Irrelevant to the drug metabolism in patients (compare with Allele A)		[ 14]
Tacrolimus	Drug Info	Kidney Transplantation	Irrelevant to the drug metabolism in patients (compare with Allele A)		[ 14]
Carbamazepine	Drug Info	Epilepsy	Irrelevant to the drug metabolism in patients (compare with Allele A); Irrelevant to the increased drug response in patients (compare with Allele T)		[ 15], [ 16]
Pravastatin	Drug Info	Hyperlipoproteinemia	Irrelevant to the drug response in patients (compare with allele A)		[ 17]
Valproic acid	Drug Info	Epilepsy	Irrelevant to the increased drug response in patients (compare with Allele T)		[ 15]
Phenytoin	Drug Info	Epilepsy	Irrelevant to the increased drug response in patients (compare with Allele T)		[ 15]
Phenobarbital	Drug Info	Epilepsy	Irrelevant to the increased drug response in patients (compare with Allele T)		[ 15]
Fluoxetine	Drug Info	Depressive Disorder	Irrelevant to the increased fluoxetine/in patients (S)-norfluoxetine ratio in patients (compare with Allele A)		[ 10]
Antiepileptics	N.A.	Epilepsy	Irrelevant to the drug response in patients (compare with Allele A)		[ 19], [ 20]
Allele T	Click to Show/Hide the Full List of Affected Drugs:            5 Drugs in Total
Carbamazepine	Drug Info	Epilepsy	Correlated with the drug-resistant phenotype in patients (compare with allele C)		[ 20]
Valproic acid	Drug Info	Epilepsy	Correlated with the drug-resistant phenotype in patients (compare with allele C)		[ 20]
Phenytoin	Drug Info	Epilepsy	Correlated with the drug-resistant phenotype in patients (compare with allele C)		[ 20]
Atorvastatin	Drug Info	Hypercholesterolemia	Correlated with the increased drug response in patients (compare with allele A); Correlated with the increased drug response in patients(compare with allele C)		[ 21]
Clopidogrel	Drug Info	Coronary Artery Disease	Correlated with the increased Hemorrhage risk in patients (compare with allele A)		[ 22]
Genotype AA	Click to Show/Hide the Full List of Affected Drugs:          17 Drugs in Total
Doxorubicin	Drug Info	Breast Neoplasm	Correlated with the decreased drug metabolism in patients (compare with genotype CC)		[ 23]
Doxorubicin	Drug Info	Leukemia	Correlated with the decreased drug metabolism in patients (compare with genotype CC)		[ 23]
Anastrozole	Drug Info	Breast Neoplasm	Correlated with the increased drug concentrations in patients (compare with genotypes AC + CC)		[ 24]
Tramadol	Drug Info	Pain	Correlated with the increased drug exposure (compare with genotype CC)		[ 25]
Cyclosporine	Drug Info	Ulcerative Colitis	Correlated with the increased drug resistance risk in patients (compare with genotypes CC + AC)		[ 26]
Cyclosporine	Drug Info	Myasthenia Gravis	Correlated with the increased drug trough blood concentration in patients (compare with genotype CC)		[ 27]
Carbamazepine	Drug Info	Epilepsy	Correlated with the increased likelihood of drug resistance in patients (compare with genotype CC)		[ 16]
Fentanyl	Drug Info	Postoperative Pain	Correlated with the increased likelihood of respiratory insufficiency in patients (compare with Genotype AA)		[ 29]
Simvastatin	Drug Info	Hypercholesterolemia	Correlated with the increased reduction in total cholesterol in patients (compare with genotype CC)		[ 30]
Mitoxantrone	Drug Info	Breast Neoplasm	Correlated with the increased sensitivity to drug in vitro (compare with genotypes CC + AC)		[ 31]
Daunorubicin	Drug Info	Acute Myeloid Leukemia	Irrelevant to the drug response in patients (compare with genotypes AC + CC)		[ 32]
Cytarabine	Drug Info	Acute Myeloid Leukemia	Irrelevant to the drug response in patients (compare with genotypes AC + CC)		[ 32]
Nevirapine	Drug Info	HIV Infection	Irrelevant to the drug metabolism in patients (compare with genotype CC)		[ 33]
Dexrazoxane	Drug Info	Acute Myeloid Leukemia	Irrelevant to the drug response in patients (compare with genotypes AC + CC)		[ 32]
Efavirenz	Drug Info	HIV Infection	Correlated with the decreased drug concentrations in patients (compare with genotypes AC + CC); Irrelevant to the drug metabolism in patients (compare with genotype CC)		[ 33], [ 34]
Idarubicin	Drug Info	Acute Myeloid Leukemia	Irrelevant to the drug response in patients (compare with genotypes AC + CC)		[ 32]
Antiepileptics	N.A.	Epilepsy	Correlated with the increased likelihood of drug resistance in patients (compare with genotype CC)		[ 16]
Genotype AC	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Methadone	Drug Info	Opioid-Related Disorders	Correlated with the increased drug concentrations in patients (compare with genotypes AA + CC)		[ 34]
Simvastatin	Drug Info	Hypercholesterolemia	Correlated with the increased reduction in total cholesterol in patients (compare with genotype CC)		[ 29]
Genotype AT	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Tacrolimus	Drug Info	Kidney Transplantation	Irrelevant to the drug clearance in patients (compare with allele C)		[ 35]
Cyclosporine	Drug Info	Kidney Transplantation	Irrelevant to the drug clearance in patients (compare with allele C)		[ 35]
Genotype CC	Click to Show/Hide the Full List of Affected Drugs:          13 Drugs in Total
Methadone	Drug Info	Opioid-Related Disorders	Correlated with the decreased drug clearance in patients (compare with genotypes AC + Ct)		[ 36]
Rivaroxaban	Drug Info	Healthy Individuals	Correlated with the decreased drug exposure in healthy individuals (compare with genotypes AA + AC)		[ 37]
Dabigatran	Drug Info	Healthy Individuals	Correlated with the decreased drug exposure in healthy individuals (compare with genotypes AA + AC)		[ 37]
Verapamil	Drug Info	Healthy Individuals	Correlated with the decreased drug metabolism in healthy individuals (compare with genotypes AA + AC)		[ 38]
Cytarabine	Drug Info	Acute Multiple Myeloma	Correlated with the decreased survival in patients (compare with genotypes AA + AC)		[ 30]
Cyclosporine	Drug Info	Cystic Fibrosis	Correlated with the increased drug clearance in patients (compare with genotype AA)		[ 40]
Dicloxacillin	Drug Info	Cystic Fibrosis	Correlated with the increased drug clearance in patients (compare with genotype AA)		[ 40]
Digoxin	Drug Info	Congestive Cardiac Insufficiency; Arrhythmias; Heart Failure	Correlated with the increased drug metabolism (compare with genotype AA)		[ 41]
Temsirolimus	Drug Info	Urinary Bladder Neoplasm	Correlated with the increased drug metabolism in patients (compare with genotypes AA + AC)		[ 42]
Atorvastatin	Drug Info	Hypercholesterolemia	Correlated with the increased drug response in patients (compare with genotype AA)		[ 43]
Pravastatin	Drug Info	Acute Coronary Syndrome	Correlated with the increased percent reduction in LDL-cholesterol in patients		[ 44]
Capecitabine	Drug Info	Colorectal Neoplasm	Correlated with the increased hand-foot syndrome risk in patients (compare with genotype AA)		[ 45]
Anthracyclines	N.A.	Breast Neoplasm	Correlated with the increased drug resistance risk in patients (compare with genotype AC)		[ 46]
Genotypes AA + AC	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Atorvastatin	Drug Info	Hypercholesterolemia	Correlated with the increased drug response in patients (compare with genotype CC)		[ 46]
Cytarabine	Drug Info	Acute Myeloid Leukemia	Irrelevant to the increased overall survival in patients (compare with genotype CC)		[ 47]
Genotypes AA + AT	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Sunitinib	Drug Info	Renal Cell Carcinoma	Correlated with the decreased overall survival in patients (compare with genotypes AC + CC)		[ 48]
Paclitaxel	Drug Info	Ovarian Neoplasm	Correlated with the increased drug response in patients (compare with genotypes AC + CC)		[ 49]
Genotypes AA + TT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Tacrolimus	Drug Info	Nephrotic Syndrome	Correlated with the increased drug response in patients (compare with genotypes CC + CT)		[ 50]
Genotypes AC + CC	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Cyclosporine	Drug Info	Kidney Transplantation	Correlated with the decreased drug dose-adjusted trough concentrations as in patients (compare with genotypes AA + Ct); Correlated with the increased drug dose in patients (compare with genotypes AA + Ct)		[ 51]
Ritonavir	Drug Info	HIV Infection	Correlated with the drug concentrations in patients (compare with genotype AA)		[ 52]
Tacrolimus	Drug Info	Kidney Transplantation	Correlated with the increased drug dose-adjusted trough concentrations in patients (compare with genotype AA)		[ 53]
Fentanyl	Drug Info	Neoplasm	Correlated with the increased likelihood of constipation in patients (compare with genotype AA)		[ 54]
Genotypes AC + CT	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Tacrolimus	Drug Info	Kidney Transplantation	Correlated with the increased drug trough concentrations in patients (compare with genotype CC)		[ 55]
Modafinil	Drug Info	Narcolepsy	Correlated with the increased drug response in patients (compare with genotype CC)		[ 56]
Genotypes CC + CT	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Fentanyl	Drug Info	Neoplasm	Correlated with the increased likelihood of constipation in patients (compare with Genotype TT)		[ 54]
Tacrolimus	Drug Info	Kidney Transplantation	Irrelevant to the drug metabolism in patients (compare with genotypes AC + At)		[ 58]
Genotypes CT + TT	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Doxorubicin	Drug Info	Breast Neoplasm	Correlated with the decreased survival in patients(compare with Genotypes AC + CC)		[ 58]
Cyclophosphamide	Drug Info	Breast Neoplasm	Correlated with the decreased survival in patients(compare with Genotypes AC + CC)		[ 58]
Genotypes AT + CT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Efavirenz	Drug Info	HIV Infection	Irrelevant to the increased drug plasma exposure in patients (compare with genotypes CC + CT)		[ 11]
Genetic Polymorphism	rs11983225
Site of GPD	chr7:87532204 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	T>C
Minor Allele Frequency	C=0.1456/729 (Global)
Allele C	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele T)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele T)		[ 59]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele T)		[ 59]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele T)		[ 59]
Genetic Polymorphism	rs12720067
Site of GPD	chr7:87540040 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>T
Minor Allele Frequency	T=0.0899/450 (Global)
Allele T	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Genetic Polymorphism	rs17160359
Site of GPD	chr7:87717503 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A / G>T
Minor Allele Frequency	T=0.0092/46 (Global)
Allele T	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Fluorouracil	Drug Info	Neoplasm	Correlated with the increased drug response in patients (compare with allele G)		[ 60]
Capecitabine	Drug Info	Neoplasm	Correlated with the increased drug response in patients (compare with allele G)		[ 60]
Genetic Polymorphism	rs1922242
Site of GPD	chr7:87544351 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>T
Minor Allele Frequency	T=0.3790/1898 (Global)
Genotype AA	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Fluvastatin	Drug Info	Hypercholesterolemia	Correlated with the increased drug response in patients (compare with genotype At)		[ 61]
Genetic Polymorphism	rs2032583
Site of GPD	chr7:87531245 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>G
Minor Allele Frequency	G=0.1454/728 (Global)
Allele G	Click to Show/Hide the Full List of Affected Drugs:            5 Drugs in Total
Citalopram	Drug Info	Major Depressive Disorder	Correlated with the increased likelihood of adverse effects in patients (compare with Allele A)		[ 62]
Fluvoxamine	Drug Info	Major Depressive Disorder	Correlated with the increased likelihood of adverse effects in patients (compare with Allele A)		[ 62]
Venlafaxine	Drug Info	Major Depressive Disorder	Correlated with the increased likelihood of adverse effects in patients (compare with Allele A)		[ 62]
Sertraline	Drug Info	Major Depressive Disorder	Correlated with the increased likelihood of adverse effects in patients (compare with Allele A)		[ 62]
Paroxetine	Drug Info	Major Depressive Disorder	Correlated with the increased likelihood of adverse effects in patients (compare with Allele A)		[ 62]
Genotype GG	Click to Show/Hide the Full List of Affected Drugs:            9 Drugs in Total
Citalopram	Drug Info	Bipolar Disorder	Irrelevant to the drug response in patients (compare with genotypes AA + AG)		[ 63]
Amitriptyline	Drug Info	Bipolar Disorder	Irrelevant to the drug response in patients (compare with genotypes AA + AG)		[ 63]
Venlafaxine	Drug Info	Bipolar Disorder	Irrelevant to the drug response in patients (compare with genotypes AA + AG)		[ 63]
Sertraline	Drug Info	Bipolar Disorder	Irrelevant to the drug response in patients (compare with genotypes AA + AG)		[ 63]
Escitalopram	Drug Info	Bipolar Disorder	Irrelevant to the drug response in patients (compare with genotypes AA + AG)		[ 63]
Paroxetine	Drug Info	Bipolar Disorder	Irrelevant to the drug response in patients (compare with genotypes AA + AG)		[ 63]
Nortriptyline	Drug Info	Bipolar Disorder	Irrelevant to the drug response in patients (compare with genotypes AA + AG)		[ 63]
Trimipramine	Drug Info	Bipolar Disorder	Irrelevant to the drug response in patients (compare with genotypes AA + AG)		[ 63]
Selective serotonin reuptake inhibitors	N.A.	Bipolar Disorder	Irrelevant to the drug response in patients (compare with genotypes AA + AG)		[ 63]
Genotypes AG + GG	Click to Show/Hide the Full List of Affected Drugs:            7 Drugs in Total
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with genotype AA)		[ 59]
Fluvoxamine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with genotype AA)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with genotype AA)		[ 59]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with genotype AA)		[ 59]
Sertraline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with genotype AA)		[ 59]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with genotype AA)		[ 59]
Antidepressants	N.A.	Depression	Correlated with the increased likelihood of remission in patients (compare with genotype AA)		[ 59]
Genetic Polymorphism	rs2229109
Site of GPD	chr7:87550493 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>A / C>T
Minor Allele Frequency	T=0.0126/63 (Global)
Allele C	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Dexamethasone	Drug Info	Multiple Myeloma	Irrelevant to the anemia, neutropenia or thrombocytopenia risk in patients (compare with Allele T)		[ 64]
Lenalidomide	Drug Info	Multiple Myeloma	Irrelevant to the anemia, neutropenia or thrombocytopenia risk in patients (compare with Allele T)		[ 64]
Genotype CT	Click to Show/Hide the Full List of Affected Drugs:          14 Drugs in Total
Vincristine	Drug Info	Non-Hodgkin Lymphoma	Correlated with the increased diarrhea and vomiting risk in patients (compare with genotype CC)		[ 65]
Doxorubicin	Drug Info	Non-Hodgkin Lymphoma	Correlated with the increased diarrhea and vomiting risk in patients (compare with genotype CC)		[ 65]
Cyclophosphamide	Drug Info	Non-Hodgkin Lymphoma	Correlated with the increased diarrhea and vomiting risk in patients (compare with genotype CC)		[ 65]
Methotrexate	Drug Info	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Correlated with the increased drug resistance in patients (compare with genotype CC)		[ 66]
Vincristine	Drug Info	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Correlated with the increased drug resistance in patients (compare with genotype CC)		[ 66]
Doxorubicin	Drug Info	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Correlated with the increased drug resistance in patients (compare with genotype CC)		[ 66]
Prednisolone	Drug Info	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Correlated with the increased drug resistance in patients (compare with genotype CC)		[ 66]
Dexamethasone	Drug Info	Multiple Myeloma	Correlated with the increased likelihood of progression-free survival in patients (compare with genotype CC); Irrelevant to the likelihood of overall survival in patients (compare with genotype CC)		[ 64]
Lenalidomide	Drug Info	Multiple Myeloma	Correlated with the increased likelihood of progression-free survival in patients (compare with genotype CC); Irrelevant to the likelihood of overall survival in patients (compare with genotype CC)		[ 64]
Valganciclovir	Drug Info	Kidney Transplantation	Correlated with the increased neutropenia risk in patients (compare with genotype CC)		[ 68]
Prednisone	Drug Info	Non-Hodgkin Lymphoma	Correlated with the increased diarrhea and vomiting risk in patients (compare with genotype CC)		[ 65]
Rituximab	Drug Info	Non-Hodgkin Lymphoma	Correlated with the increased diarrhea and vomiting risk in patients (compare with genotype CC)		[ 65]
Bleomycin	Drug Info	Non-Hodgkin Lymphoma	Correlated with the increased diarrhea and vomiting risk in patients (compare with genotype CC)		[ 65]
Vindesine	Drug Info	Non-Hodgkin Lymphoma	Correlated with the increased diarrhea and vomiting risk in patients (compare with genotype CC)		[ 65]
Genotypes CT + TT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Tacrolimus	Drug Info	Kidney Transplantation	Correlated with the increased renal transplant failure risk in patients (compare with genotype CC)		[ 68]
Genetic Polymorphism	rs2235015
Site of GPD	chr7:87570248 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>A / C>T
Minor Allele Frequency	A=0.2157/1080 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Genotype AA	Click to Show/Hide the Full List of Affected Drugs:            9 Drugs in Total
Citalopram	Drug Info	Depression	Irrelevant to the drug response in patients (compare with genotypes AA + AC)		[ 63]
Amitriptyline	Drug Info	Depression	Irrelevant to the drug response in patients (compare with genotypes AA + AC)		[ 63]
Venlafaxine	Drug Info	Depression	Irrelevant to the drug response in patients (compare with genotypes AA + AC)		[ 63]
Sertraline	Drug Info	Depression	Irrelevant to the drug response in patients (compare with genotypes AA + AC)		[ 63]
Escitalopram	Drug Info	Depression	Irrelevant to the drug response in patients (compare with genotypes AA + AC)		[ 63]
Paroxetine	Drug Info	Depression	Irrelevant to the drug response in patients (compare with genotypes AA + AC)		[ 63]
Nortriptyline	Drug Info	Depression	Irrelevant to the drug response in patients (compare with genotypes AA + AC)		[ 63]
Trimipramine	Drug Info	Depression	Irrelevant to the drug response in patients (compare with genotypes AA + AC)		[ 63]
Selective serotonin reuptake inhibitors	N.A.	Depression	Irrelevant to the drug response in patients (compare with genotypes AA + AC)		[ 63]
Genetic Polymorphism	rs2235040
Site of GPD	chr7:87536434 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>A / C>G / C>T
Minor Allele Frequency	T=0.1396/699 (Global)
Allele T	Click to Show/Hide the Full List of Affected Drugs:            9 Drugs in Total
Citalopram	Drug Info	Major Depressive Disorder	Correlated with the increased likelihood of adverse effects in patients (compare with allele C)		[ 62]
Fluvoxamine	Drug Info	Major Depressive Disorder	Correlated with the increased likelihood of adverse effects in patients (compare with allele C)		[ 62]
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Venlafaxine	Drug Info	Major Depressive Disorder	Correlated with the increased likelihood of adverse effects in patients (compare with allele C)		[ 62]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Sertraline	Drug Info	Major Depressive Disorder	Correlated with the increased likelihood of adverse effects in patients (compare with allele C)		[ 62]
Paroxetine	Drug Info	Major Depressive Disorder	Correlated with the increased likelihood of adverse effects in patients (compare with allele C)		[ 62]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Genotype CT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Imatinib	Drug Info	Gastrointestinal Stromal Tumors	Correlated with the decreased periorbital edema risk in patients (compare with genotype CC)		[ 69]
Genetic Polymorphism	rs2235047
Site of GPD	chr7:87509216 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>C / A>G
Minor Allele Frequency	C=0.1745/874 (Global)
Allele C	Click to Show/Hide the Full List of Affected Drugs:            3 Drugs in Total
Daunorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele A)		[ 70]
Doxorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele A)		[ 70]
Anthracyclines	N.A.	Neoplasm	Correlated with the increased likelihood of cardiotoxicity in patients (compare with Allele A)		[ 71]
Genetic Polymorphism	rs2235067
Site of GPD	chr7:87520606 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>T
Minor Allele Frequency	T=0.1338/670 (Global)
Allele T	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Genetic Polymorphism	rs28401781
Site of GPD	chr7:87519012 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>T
Minor Allele Frequency	T=0.1474/738 (Global)
Allele T	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Citalopram	Drug Info	Major Depressive Disorder	Correlated with the increased drug response in patients (compare with allele C)		[ 72]
Fluoxetine	Drug Info	Major Depressive Disorder	Correlated with the increased drug response in patients (compare with allele C)		[ 72]
Sertraline	Drug Info	Major Depressive Disorder	Correlated with the increased drug response in patients (compare with allele C)		[ 72]
Paroxetine	Drug Info	Major Depressive Disorder	Correlated with the increased drug response in patients (compare with allele C)		[ 72]
Genetic Polymorphism	rs3213619
Site of GPD	chr7:87600877 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>G
Minor Allele Frequency	G=0.0543/272 (Global)
Allele G	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Atenolol	Drug Info	Hypertension	Correlated with the increased hypercholesterolemia risk in patients (compare with Allele A)		[ 73]
Genetic Polymorphism	rs3789243
Site of GPD	chr7:87591570 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>G
Minor Allele Frequency	A=0.4635/2321 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Antiepileptics	N.A.	Epilepsy	Irrelevant to the likelihood of drug resistance in patients (compare with Allele G)		[ 12]
Genetic Polymorphism	rs4148737
Site of GPD	chr7:87541836 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	T>C
Minor Allele Frequency	C=0.3790/1898 (Global)
Allele C	Click to Show/Hide the Full List of Affected Drugs:            7 Drugs in Total
Methotrexate	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with Allele T)		[ 74]
Vincristine	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with Allele T)		[ 74]
Cisplatin	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with Allele T)		[ 74]
Doxorubicin	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with Allele T)		[ 74]
Cyclophosphamide	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with Allele T)		[ 74]
Doxorubicin	Drug Info	Breast Neoplasm	Irrelevant to the drug response in patients (compare with Allele T)		[ 75]
Cyclophosphamide	Drug Info	Breast Neoplasm	Irrelevant to the drug response in patients (compare with Allele T)		[ 75]
Genetic Polymorphism	rs4148739
Site of GPD	chr7:87531733 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	T>C
Minor Allele Frequency	C=0.1454/728 (Global)
Allele C	Click to Show/Hide the Full List of Affected Drugs:          11 Drugs in Total
Citalopram	Drug Info	Major Depressive Disorder	Correlated with the increased drug response in patients (compare with Allele T)		[ 72]
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele T)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele T)		[ 59]
Fluoxetine	Drug Info	Major Depressive Disorder	Correlated with the increased drug response in patients (compare with Allele T)		[ 72]
Fluoxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele T)		[ 59]
Venlafaxine	Drug Info	Major Depressive Disorder	Correlated with the increased drug response in patients (compare with Allele T)		[ 72]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele T)		[ 59]
Sertraline	Drug Info	Major Depressive Disorder	Correlated with the increased drug response in patients (compare with Allele T)		[ 72]
Sertraline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele T)		[ 59]
Paroxetine	Drug Info	Major Depressive Disorder	Correlated with the increased drug response in patients (compare with Allele T)		[ 72]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele T)		[ 59]
Genotype TT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Carbamazepine	Drug Info	Epilepsy	Correlated with the decreased drug metabolism in patients (compare with genotype Ct)		[ 76]
Genetic Polymorphism	rs4148740
Site of GPD	chr7:87522787 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>G
Minor Allele Frequency	G=0.1446/724 (Global)
Allele G	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Genotype AG	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Carbamazepine	Drug Info	Epilepsy	Correlated with the increased drug metabolism in patients (compare with genotype AA)		[ 76]
Genetic Polymorphism	rs4728709
Site of GPD	chr7:87604286 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	A=0.1769/886 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Vincristine	Drug Info	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Correlated with the decreased neurotoxicity syndromes risk in patients (compare with allele G)		[ 77]
Genetic Polymorphism	rs7787082
Site of GPD	chr7:87527735 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	A=0.3778/1892 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with allele C)		[ 59]
Allele G	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Clozapine	Drug Info	Schizophrenia	Correlated with the decreased drug response in patients (compare with Allele A)		[ 78]
Genetic Polymorphism	rs9282564
Site of GPD	chr7:87600124 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	T>A / T>C / T>G
Minor Allele Frequency	C=0.0260/130 (Global)
Allele C	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methadone	Drug Info	Opioid-Related Disorders	Correlated with the decreased drug clearance in patients (compare with Allele T)		[ 79]
Allele T	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Tacrolimus	Drug Info	Kidney Transplantation	Irrelevant to the drug trough concentration in patients (compare with allele C)		[ 80]
Genotype CT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Tacrolimus	Drug Info	Lung Transplantation	Correlated with the increased drug concentrations in patients (compare with Genotype TT)		[ 81]
Genotypes CC + CT	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Tacrolimus	Drug Info	Kidney Transplantation	Correlated with the decreased drug dose-adjusted trough concentrations in patients (compare with Genotype TT)		[ 82]
Morphine	Drug Info	Neoplasm	Correlated with the increased respiratory insufficiency risk (compare with Genotype TT)		[ 83]
Genetic Polymorphism	rs10248420
Site of GPD	chr7:87535670 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>G / A>T
Minor Allele Frequency	G=0.3474/1740 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Clozapine	Drug Info	Schizophrenia	Correlated with the decreased drug response in patients (compare with allele G)		[ 78]
Allele G	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Genetic Polymorphism	rs10267099
Site of GPD	chr7:87649444 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	G=0.1434/718 (Global)
Allele G	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Atenolol	Drug Info	Hypertension	Correlated with the increased hypercholesterolemia risk in patients (compare with Allele A)		[ 73]
Genetic Polymorphism	rs10276036
Site of GPD	chr7:87550882 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>A / C>T
Minor Allele Frequency	C=0.4323/2165 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Doxorubicin	Drug Info	Breast Neoplasm	Irrelevant to the drug response in patients (compare with Allele T)		[ 75]
Cyclophosphamide	Drug Info	Breast Neoplasm	Irrelevant to the drug response in patients (compare with Allele T)		[ 75]
Allele C	Click to Show/Hide the Full List of Affected Drugs:            5 Drugs in Total
Methotrexate	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with Allele T)		[ 74]
Vincristine	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with Allele T)		[ 74]
Cisplatin	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with Allele T)		[ 74]
Doxorubicin	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with Allele T)		[ 74]
Cyclophosphamide	Drug Info	Osteosarcoma	Correlated with the increased death risk in patients (compare with Allele T)		[ 74]
Genetic Polymorphism	rs10280101
Site of GPD	chr7:87524269 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>C / A>G
Minor Allele Frequency	C=0.1446/724 (Global)
Allele C	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Citalopram	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Amitriptyline	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Venlafaxine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Paroxetine	Drug Info	Depression	Correlated with the increased likelihood of remission in patients (compare with Allele A)		[ 59]
Genetic Polymorphism	rs3842
Site of GPD	chr7:87504050 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	T>C
Minor Allele Frequency	C=0.1879/941 (Global)
Allele C	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Efavirenz	Drug Info	HIV Infection	Correlated with the drug concentrations in patients (compare with Allele T); Correlated with the drug metabolism in patients (compare with Allele T); Irrelevant to the drug concentrations in patients (compare with Allele T)		[ 84], [ 85], [ 86]
Genotypes CC + CT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Efavirenz	Drug Info	HIV Infection	Correlated with the increased drug accumulation in patients (compare with Genotype TT); Correlated with the increased drug trough concentration in patients (compare with Genotype TT)		[ 87], [ 88]
Genetic Polymorphism	rs12720066
Site of GPD	chr7:87540386 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>C
Minor Allele Frequency	C=0.0212/106 (Global)
Genotypes AC + CC	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Irinotecan	Drug Info	Colorectal Neoplasm	Correlated with the increased severity of neutropenia in patients (compare with genotype AA)		[ 89]
Genetic Polymorphism	rs4148738
Site of GPD	chr7:87533733 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>T
Minor Allele Frequency	C=0.3814/1910 (Global)
Genotypes CT + TT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Dabigatran	Drug Info	Atrial Fibrillation	Correlated with the decreased drug concentrations in patients (compare with genotype CC)		[ 90]
References
1	Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration. Pharmacogenet Genomics. 2008 Apr;18(4):299-305.
2	Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer. PLoS One. 2017 Jul 20;12(7):e0180192.
3	Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int. 2008 Sep;21(9):879-91.
4	Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy. Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):75-81.
5	Long-Term Influence of CYP3A5, CYP3A4, ABCB1, and NR1I2 Polymorphisms on Tacrolimus Concentration in Chinese Renal Transplant Recipients. Genet Test Mol Biomarkers. 2017 Nov;21(11):663-673.
6	MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients. Br J Clin Pharmacol. 2004 Nov;58(5):548-53.
7	Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT. Bone Marrow Transplant. 2011 Jan;46(1):90-7.
8	Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients. Exp Clin Transplant. 2015 Oct;13(5):441-8.
9	Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample. Pharmacogenomics. 2011 Mar;12(3):365-77.
10	Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients. Pharmacogenomics J. 2014 Oct;14(5):457-62.
11	Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study. J Infect Dis. 2005 Dec 1;192(11):1931-42.
12	The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Epilepsy Res. 2007 Feb;73(2):192-8.
13	ABCB1 polymorphism is associated with atorvastatin-induced liver injury in Japanese population. BMC Genet. 2016 Jun 13;17(1):79.
14	CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients. Springerplus. 2015 Oct 23;4:637.
15	Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients. Biochimie. 2010 Sep;92(9):1207-12.
16	ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics. 2006 Jun;7(4):551-61.
17	Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes. Br J Clin Pharmacol. 2006 Jun;61(6):706-15.
18	Single nucleotide polymorphisms in the multidrug resistance 1 gene in Korean epileptics. Seizure. 2006 Jan;15(1):67-72.
19	Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: a systematic review and meta-analysis. Pharmacogenomics. 2011 May;12(5):713-25.
20	Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population. Indian J Hum Genet. 2011 May;17 Suppl 1:S32-40.
21	ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment. Biochem Pharmacol. 2009 Jan 1;77(1):66-75.
22	Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention. Eur J Clin Pharmacol. 2017 Sep;73(9):1085-1094.
23	Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients. Cancer Sci. 2008 Apr;99(4):816-23.
24	Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients. Br J Clin Pharmacol. 2017 Mar;83(3):562-571.
25	Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose. Forensic Sci Int. 2014 May;238:125-32.
26	Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis. Inflamm Bowel Dis. 2007 Jan;13(1):19-23.
27	ABCB1 polymorphisms may have a minor effect on ciclosporin blood concentrations in myasthenia gravis patients. Br J Clin Pharmacol. 2008 Aug;66(2):240-6.
28	Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans. Clin Pharmacol Ther. 2007 Apr;81(4):539-46.
29	Common genetic variation in the ABCB1 gene is associated with the cholesterol-lowering effect of simvastatin in males. Pharmacogenomics. 2009 Nov;10(11):1743-51.
30	Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype. Pharmacogenomics J. 2012 Apr;12(2):111-8.
31	Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia. Eur J Clin Pharmacol. 2015 Mar;71(3):293-302.
32	CYP2B6 polymorphism and nonnucleoside reverse transcriptase inhibitor plasma concentrations in Chinese HIV-infected patients. Ther Drug Monit. 2010 Oct;32(5):573-8.
33	Efavirenz pharmacogenetics in a cohort of Italian patients. Int J Antimicrob Agents. 2016 Feb;47(2):117-23.
34	Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT). Am J Drug Alcohol Abuse. 2016 Sep;42(5):587-596.
35	Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients. Pharmacogenomics. 2011 Sep;12(9):1293-303.
36	Ethnic and genetic factors in methadone pharmacokinetics: a population pharmacokinetic study. Drug Alcohol Depend. 2014 Dec 1;145:185-93.
37	Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin. J Thromb Haemost. 2017 Feb;15(2):273-283.
38	Influence of ABCB1 gene polymorphisms on the pharmacokinetics of verapamil among healthy Chinese Han ethnic subjects. Br J Clin Pharmacol. 2009 Sep;68(3):395-401.
39	Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis. Pharmacotherapy. 2008 Jul;28(7):883-94.
40	Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clin Pharmacol Ther. 2002 Aug;72(2):209-19.
41	Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer Chemother Pharmacol. 2017 Sep;80(3):653-659.
42	An association study of 43 SNPs in 16 candidate genes with atorvastatin response. Pharmacogenomics J. 2005;5(6):352-8.
43	Identification of genetic variants associated with response to statin therapy. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1310-5.
44	ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients. Pharmacogenomics. 2010 Dec;11(12):1715-23.
45	Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. Ann Oncol. 2009 Feb;20(2):272-7.
46	Genetic determinants of lipid-lowering response to atorvastatin therapy in an Indian population. J Clin Pharm Ther. 2016 Jun;41(3):329-33.
47	Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies. Pharmacogenomics J. 2015 Apr;15(2):109-18.
48	Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib. Acta Oncol. 2014 Oct;53(10):1413-22.
49	mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):854-9.
50	Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome. BMC Pharmacol Toxicol. 2018 Apr 3;19(1):14.
51	Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients. Mol Biol Rep. 2015 Jan;42(1):105-17.
52	Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. J Antimicrob Chemother. 2014 Nov;69(11):3061-6.
53	The importance of MDR1 gene polymorphisms for tacrolimus dosage. Eur J Pharm Sci. 2016 Feb 15;83:109-13.
54	Impact of CYP3A5 and ABCB1 gene polymorphisms on fentanyl pharmacokinetics and clinical responses in cancer patients undergoing conversion to a transdermal system. Drug Metab Pharmacokinet. 2012;27(4):414-21.
55	Genetic polymorphisms in CYP3A5 and MDR1 genes and their correlations with plasma levels of tacrolimus and cyclosporine in renal transplant recipients. Transplant Proc. 2009 Apr;41(3):840-2.
56	Pharmacogenetics and Treatment Response in Narcolepsy Type 1: Relevance of the Polymorphisms of the Drug Transporter Gene ABCB1. Clin Neuropharmacol. 2016 Jan-Feb;39(1):18-23.
57	Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients. Br J Clin Pharmacol. 2008 Aug;66(2):207-14.
58	Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide. Br J Cancer. 2010 Mar 16;102(6):1003-9.
59	Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron. 2008 Jan 24;57(2):203-9.
60	Potentially functional SNPs (pfSNPs) as novel genomic predictors of 5-FU response in metastatic colorectal cancer patients. PLoS One. 2014 Nov 5;9(11):e111694.
61	The association of common SNPs and haplotypes in the CETP and MDR1 genes with lipids response to fluvastatin in familial hypercholesterolemia. Atherosclerosis. 2006 Mar;185(1):97-107.
62	ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder. Pharmacogenomics J. 2013 Aug;13(4):349-53.
63	Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study. J Psychiatr Res. 2016 Feb;73:86-95.
64	Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial. Cancer Chemother Pharmacol. 2018 Jan;81(1):183-193.
65	Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma. Haematologica. 2015 May;100(5):e204-6.
66	Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia. Pharmacogenomics J. 2015 Aug;15(4):372-9.
67	Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients. Pharmacol Res. 2016 Sep;111:501-508.
68	A donor and recipient candidate gene association study of allograft loss in renal transplant recipients receiving a tacrolimus-based regimen. Am J Transplant. 2018 Dec;18(12):2905-2913.
69	Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1. Pharmacogenomics J. 2018 May 22;18(3):460-466.
70	Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer. 2013 Aug;60(8):1375-81.
71	Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol. 2012 May 1;30(13):1422-8.
72	ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients. Pharmacogenomics. 2013 Nov;14(14):1723-30.
73	Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study. PLoS One. 2013 Oct 7;8(10):e76984.
74	Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study. PLoS One. 2011;6(10):e26091.
75	Association of CYP2C19*2 and ALDH1A1*1/*2 variants with disease outcome in breast cancer patients: results of a global screening array. Eur J Clin Pharmacol. 2018 Oct;74(10):1291-1298.
76	Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Pharmacogenomics. 2013 Jan;14(1):35-45.
77	Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia. Pharmacogenomics. 2014 Jun;15(8):1105-16.
78	Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response. J Clin Psychopharmacol. 2012 Aug;32(4):441-8.
79	ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment. Clin Pharmacol Ther. 2006 Dec;80(6):668-81.
80	Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients. Pharmacogenomics. 2018 Feb;19(3):175-184.
81	Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation. Int J Mol Sci. 2015 Aug 25;16(9):20168-82.
82	CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation. Basic Clin Pharmacol Toxicol. 2018 Sep;123(3):320-326.
83	Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. Pharmacogenomics J. 2015 Apr;15(2):119-26.
84	CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure. Pharmacogenomics. 2014 Aug;15(11):1423-35.
85	Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes. PLoS One. 2014 Jan 31;9(1):e86919.
86	Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin. PLoS One. 2017 Sep 8;12(9):e0181316.
87	Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients. Pharmacogenomics. 2010 Sep;11(9):1223-34.
88	CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population. Pharmacogenomics. 2016 Apr;17(6):603-13.
89	ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. Pharmacogenomics J. 2018 Jan;18(1):35-42.
90	Pharmacogenetics of dabigatran etexilate interindividual variability. Thromb Res. 2016 Aug;144:1-5.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.